HF
CPHI icon

HRT Financial’s China Pharma Holdings CPHI Stock Holding History

HRT Financial’s Portfolio CPHI Stock Details CPHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16,168
Closed -$28K – 2969
2025
Q2 		$28K Buy
16,168
+13,657
+544% +$25.1K ﹤0.01% 2363
2025
Q1 		$6K Buy
+2,511
New +$5.74K ﹤0.01% 2389
2024
Q1 		– Sell
-421
Closed -$2K – 2429
2023
Q4 		$2K Buy
+421
New +$2.36K ﹤0.01% 2170
2022
Q2 		– Sell
-34
Closed -$6K – 3033
2022
Q1 		$6K Sell
34
-92
-73% -$19.2K ﹤0.01% 2941
2021
Q4 		$30K Sell
126
-440
-78% -$120K ﹤0.01% 2906
2021
Q3 		$158K Buy
566
+44
+8% +$15.6K ﹤0.01% 2764
2021
Q2 		$188K Sell
522
-14
-3% -$5.03K ﹤0.01% 2416
2021
Q1 		$225K Buy
536
+499
+1,349% +$215K ﹤0.01% 2259
2020
Q4 		$8K Sell
37
-264
-88% -$56.7K ﹤0.01% 1762
2020
Q3 		$54K Buy
301
+182
+153% +$42K ﹤0.01% 1660
2020
Q2 		$39K Buy
+119
New +$29.4K ﹤0.01% 1333

Other funds holding CPHI

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

HRT Financial's CPHI Position: Q3 2025 in Review

HRT Financial sold out of China Pharma Holdings (CPHI) in Q3 2025, closing a stake of 16,168 shares — an estimated $28K sold.

HRT Financial first reported a position in CPHI in Q2 2020 and held it in 11 quarters. The position peaked at $225K in Q1 2021. 5 funds tracked by Wall St. Rank hold CPHI as of Q3 2025.

  • HRT Financial reported no remaining China Pharma Holdings position as of Q3 2025 after selling out during the quarter.
  • HRT Financial sold 16,168 China Pharma Holdings shares in Q3 2025, an estimated $28K.
  • HRT Financial first reported a position in China Pharma Holdings in Q2 2020 and held it in 11 quarters.
  • HRT Financial's China Pharma Holdings position peaked at $225K in Q1 2021.
  • 5 funds tracked by Wall St. Rank held China Pharma Holdings as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.